| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |